Transcriptomics

Dataset Information

0

A cross-disease human microglial framework identifies disease-enriched subsets and tool compounds for microglial polarization.


ABSTRACT: Human microglia play a pivotal role in neurological diseases, but few targeted therapies that directly modulate microglial state or function exist due to an incomplete understanding of microglial heterogeneity. We use single-cell RNA sequencing to profile live human microglia from autopsies or surgical resections across diverse neurological diseases and central nervous system regions. We observe a central divide between oxidative and heterocyclic metabolism and identify subsets associated with antigen presentation, motility, and proliferation. Specific subsets are enriched in susceptibility genes for neurodegenerative diseases or the disease-associated microglial signature. We validate subtypes in situ with an RNAscope-immunofluorescence pipeline and leverage our dataset as a classification resource, finding that iPSC model systems recapitulate substantial in vivo heterogeneity. Finally, we identify and validate candidates for chemically inducing subtype-specific states in vitro, showing that Camptothecin downregulates the transcriptional signature of disease-enriched subsets and upregulates a signature previously shown to be depleted in Alzheimer’s.

ORGANISM(S): Homo sapiens

PROVIDER: GSE202556 | GEO | 2024/10/18

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-10-18 | GSE204702 | GEO
2019-11-05 | GSE122663 | GEO
2019-11-05 | GSE135330 | GEO
2020-02-22 | GSE139161 | GEO
2023-10-24 | GSE245677 | GEO
2018-10-24 | PXD006753 | Pride
2024-04-24 | GSE253623 | GEO
2022-08-08 | GSE207570 | GEO
2015-07-06 | E-GEOD-70475 | biostudies-arrayexpress
2023-09-08 | GSE186210 | GEO